@DDDMarc

AnestRea @santearmees PhD student @U1304GETBO @ubo_univbrest

 Brest
researchgate.net/profile/Marc-Danguy-Des-Deserts
Joined December 2011
  • Tweets173
  • Following75
  • Followers33
6Media
Les résultats de l’essai STOP-or-NOT publiés ce jour dans le ⁦@JAMA_current⁩ . Merci à tous les investigateurs. @matthieulegrand ⁦@APHP⁩ ⁦@INICRCT⁩ ⁦@UCSF⁩ jamanetwork.com/journals/jam…

Continuation vs Discontinuation of RASIs Before Major Noncardiac Surgery

This randomized clinical trial compares the effect of continued use of renin-angiotensin system inhibitors (RASIs) vs discontinued use of RASIs before major noncardiac surgery on postoperative...

jamanetwork.com
2
7
3
31
3,697
The Stop-or-Not Trial published with the hotline session ⁦@escardio⁩ in ⁦@JAMA_current⁩ 🙏to all investigators, staffs and patients for making it possible @etiennegayat @aphp ⁦@INICRCT⁩ @UCSFAnesthesia⁩ ⁦⁦@ucsfccm⁩ jamanetwork.com/journals/jam…

Continuation vs Discontinuation of RASIs Before Major Noncardiac Surgery

This randomized clinical trial compares the effect of continued use of renin-angiotensin system inhibitors (RASIs) vs discontinued use of RASIs before major noncardiac surgery on postoperative...

jamanetwork.com
6
21
3
55
4,985
Marc DDD retweeted
JAMA
@JAMA_current30 Aug 2024
Among patients who underwent major noncardiac surgery, renin-angiotensin system inhibitor continuation before surgery was not associated with a higher rate of postoperative complications than discontinuation. ja.ma/3MrlqUs #ESCCongress
2
33
4
83
21,432
Here is the very first basic science paper of our lab. This is a collaborative project with McGill Univ showing an important role of circulating RNA in venous thrombosis. Wonderful team effort!! @FCouturaud @U1304GETBO @UBO_UnivBrest @InsermGrdOuest ahajournals.org/doi/10.1161/…

Extracellular RNA Induces Neutrophil Recruitment Via Toll‐Like Receptor 3 During Venous Thrombosis...

ahajournals.org
2
9
27
1,362
Pour le plaisir des couleurs. Schéma de synthèse de la Prévention de la maladie thromboembolique veineuse péri-opératoire. RFE GIHP-SFAR-SFTH-SFMV, sur gihp.org @GIHP_official @SFAR_ORG @SFTHemostase @lasfmv
1
25
50
3,377
Merci @Oceanopolis_ et à tous les visiteurs pour cette superbe Nuit Européenne des chercheurs #NEDC!! Nous avons pris plaisir à parler de notre recherche sur la thrombose veineuse!! @UBO_UnivBrest @InsermGrdOuest @INNOVTE1 @FCouturaud @CatLemarie
3
1
12
1,046
Trauma resuscitation may be seen through sequential steps that occur in parallel and in series; these interventions are at both the patient and system level to optimize and individualize trauma care. @SCHMITTJohan1 #JoTACS journals.lww.com/jtrauma/Ful…
12
2
24
5,357
Quels progrès récents en traumatologie vitale ? Une réponse dans cette revue narrative de nos camarades de l’HIA de Brest @santearmees publiée dans @JTraumAcuteSurg ! #JeunesOps
Journal of Trauma and Acute Care Surgery
@JTraumAcuteSurg9 Aug 2023
Trauma resuscitation may be seen through sequential steps that occur in parallel and in series; these interventions are at both the patient and system level to optimize and individualize trauma care. @SCHMITTJohan1 #JoTACS journals.lww.com/jtrauma/Ful…
4
4
691
Marc DDD retweeted
SABM@bloodmgmt7 Aug 2023
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial. pubmed.ncbi.nlm.nih.gov/3752…

Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in...

French Ministry of Health, HiFIT trial.

pubmed.ncbi.nlm.nih.gov
12
21
1,419
Happy to share our latest paper : the HiFIT trial showing that combining treatment (Ferric derisomaltose and TXA) impoves #PBM in hip fractures @SFAR_ORG @mxmleger @EmmanuelRineau @NATAforum thelancet.com/pdfs/journals/…
8
21
2
48
6,861
Replying to @RodgerMarc @PantepAng @SusanRKahn1 @isth
From behalf @INNOVTE1 network, Many thanks and congrats to you and @isth2023 organizers for this wonderful congress. By the way, huge thanks to INNOVTE members dream team,physicians, scientists, young fellows, for their major involvement in this meeting. 🙏👏👍 @FCouturaud
2
7
229
Whether thromboprophylaxis prevents symptomatic venous thromboembolism in medically ill, hospitalized older adults remains debated. In this #RCT, older adults hospitalized for acute medical conditions were randomized to receive daily enoxaparin or placebo. #ISTH2023 #VTE

2
34
1
97
58,472
Landmark SYMPTOMS randomized trial in VTE prevention in older patients presented by Gregoire Le Gal @grelegal on behalf Dominique Mottier, Karine Lacut and @INNOVTE1 network, @u1304GETBO , #ISTH
7
17
675
For the second year in a row, Marion is presented her almost completed PhD work on HDAC6 in VTE recurrence at #ISTH2023 . Great talk Marion!! @UBO_UnivBrest @InsermGrdOuest @Inserm @INNOVTE1 @FCouturaud @CatLemarie
4
1
11
849
Postpartum haemorrhage (#PPH) is a major cause for maternal mortality and difficult to predict. @DeMoreuil shows interesting data on impaired pre-delivery thrombin generation but more research is needed to better identify women at risk. 🩸🤰📈 #ISTH2023 – at Montréal, Québec
5
1
18
1,342
Clap de fin #CfH2023 @cfh_2023 avec @GodierAnne @BorgelDelphine @StephRoullet @caterinacasari @InsermU1176 @GIHP_official, merci et 👋
3
13
854
#CFH2023 Patrick Mismetti @Sainbiose_Lab nous parle maintenant de maladie rénale & maladie thromboembolique veineuse.
6
1
20
881
En direct de @SaintMaloVille session #mtev du #CfH2023 @cfh_2023 présentations du @U1304GETBO @INNOVTE1 de @FCouturaud @CatLemarie et Patrick Mismetti 👏👏👏
5
13
472
Maintenant Catherine Lemarié @CatLemarie en séance plénière nous présente le phénotype endothélial et les mécanismes inflammatoires dans la MTV #CFH2023!
1
5
16
589
Merci a @FCouturaud pour cette présentation très intéressante en ouverture du #CFH2023! Place aux questions avec l’aide des nos modérateurs @GouinThibault et @morange_pierre
6
1
14
948
Load more